![Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition]()
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionKasner, Margaret T.; Mick, Rosemarie; Jeschke, Grace R.; Carabasi, Matthew; Filicko-O’Hara, Joanne; Flomenberg, Neal; Frey, Noelle V.; Hexner, Elizabeth O.; Luger, Selina M.; Loren, Alison W.; Mangan, James K.; Wagner, John L.; Weiss, Mark; Carroll, Martin; Perl, Alexander E. · Investigational New Drugs · 2018